Evaux announces the presentation of the results of a clinical study at the 7th International Congress on Neuropathic Pains, held in London from May 9 to 11, 2019 (7th International Congress on Neuropathic Pain)
EVAUX® innovates and launches a campaign in pharmacy to promote the observance of oncological treatments.
EVAUX® announces the presentation of clinical study results on its product EVONAIL® – a hydrating nail solution – at ASCO, an international oncology conference. EVONAIL® is proven to be an efficient ambulatory nail solution to prevent or treat nail toxicities during chemotherapy.
The EVAUX® are committed to supporting EUROPA DONNAFRANCE®, for the “Octobre Rose” 2017 campaign.